For two decades, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) has been a cornerstone of HIV response efforts across southern Africa, saving millions of lives and supporting national public health systems. Now, Namibia has become the latest southern African nation to face an impending end to this critical financial support, as the U.S. pushes forward with a continent-wide restructuring of foreign aid that has sparked disputes over national sovereignty and data privacy.
In a joint statement released by both governments, officials confirmed that the U.S. will provide Namibia $45 million in PEPFAR funding for fiscal year 2027, after which full financial responsibility for the country’s HIV programs will shift to Namibia. Going forward, U.S. involvement will be limited to technical cooperation, rather than direct financial support.
Since 2003, PEPFAR has poured more than $1.1 billion into Namibia’s HIV response, with the country receiving roughly $45 million in annual funding from the program in recent years. Remarkably, Namibia has already outperformed global targets set by UNAIDS: 96% of people living with HIV in the country know their status, 98% of those diagnosed are receiving antiretroviral treatment, and 98% of treated patients have achieved undetectable viral suppression, a milestone that both protects individual health and prevents new transmission.
The phase-out of funding had been anticipated ever since the Trump administration rolled out its “America First” foreign aid framework, which prioritizes reducing long-term donor dependency and safeguarding U.S. interests through bilateral country-specific agreements. To date, Washington has signed these new agreements with roughly 30 nations, the majority of which are located in Africa.
However, the timeline for Namibia’s funding cut follows the country’s outright rejection of controversial provisions that would have required sharing sensitive public health data and biological specimens with U.S. institutions. Namibian officials argued that the original terms of the proposed agreement violated national law, infringed on constitutional privacy protections, and undermined the country’s sovereign control over its biological resources. Both nations are currently in negotiations to finalize a new bilateral health agreement that aligns with Namibia’s domestic legal framework.
Namibia is far from alone in pushing back against the U.S. demands. Ghana rejected a similar agreement over concerns about access to sensitive health data, Zimbabwe pulled out of a $367 million U.S. aid package over identical sovereignty issues, a court challenge has delayed implementation of a $2.5 billion agreement with Kenya, and Zambia has also publicly objected to the U.S. data-sharing requirements.
The shift in Namibia comes on the heels of a similar announcement for neighboring South Africa, where the U.S. is winding down more than $400 million in annual PEPFAR funding that has supported the country’s HIV response for 20 years. Across the continent, PEPFAR is widely credited with saving more than 20 million lives from HIV and AIDS since its launch.